Portfolio Companies
Sort By:
Aptinyx
Neurology | Clinical | IPO
Clinical company developing platform of neuromodulators for neurology indications.
×
Carisma Therapeutics
Carisma Therapeutics
Oncology | Preclinical | Active
Preclinical company developing immunotherapy platform for oncology applications.
×
Orbus Therapeutics
Orbus Therapeutics
Oncology | Clinical | Active
Clinical company developing therapeutics for rare brain tumors.
×
×
Orchard Therapeutics
Orchard Therapeutics
Rare Disease, Neurology, Immunology | Commercial | IPO
Commercial company developing gene therapies for rare immunology disorders.
×
Palvella Therapeutics
Palvella Therapeutics
Rare Disease, Immunology | Clinical | Active
Clinical stage company developing therapeutics for rare dermatological disorders.
×
Pliant Therapeutics
Pliant Therapeutics
Rare Disease | Preclinical | Active
Preclinical company developing therapeutics targeting key biological pathways in fibrosis.
×
×
Precision Biosciences
Precision Biosciences
Rare Disease, Oncology | Preclinical | Active
Preclinical company developing gene-editing platform for oncology and rare diseases.
×
Skyhawk Therapeutics
Skyhawk Therapeutics
Rare Disease, Oncology, Neurology | Preclinical | Active
Preclinical company developing platform to correct RNA expression in neurology, oncology and rare diseases.
×
Verge Genomics
Verge Genomics
Neurology | Preclinical | Active
Preclinical company developing therapies for neurodegenerative diseases.
×
×
×